Home » Healthcare » Pharmaceuticals » Canada Retail Pharmacy Market

Canada Retail Pharmacy Market By Type of Pharmacy (Chain Pharmacies, Independent Pharmacies, Hospital Pharmacies, Mail Order Pharmacies, Online Pharmacies); By Type of Prescription (Prescription Drugs [Rx], Over-the-Counter [OTC] Drugs); By Service Offered (Medication Dispensing, Health Screenings, Vaccination Services, Consultation and Counseling, Chronic Disease Management); By Product Type (Generic Drugs, Branded Drugs); By Application (Oncology, Diabetes, Neurology, Other) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Name: Canada Retail Pharmacy Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2025-04-28
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: Canada Retail Pharmacy Market

Summary
Table Of Content
Request Free Sample

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Canada Retail Pharmacy Market Size 2024	SD 39,810.35 million
Canada Retail Pharmacy Market, CAGR	3.08%
Canada Retail Pharmacy Market Size 2032	USD 50,732.50 million

Market Overview

The Canada Retail Pharmacy Market is projected to grow from USD 39,810.35 million in 2024 to an estimated USD 50,732.50 million by 2032, with a compound annual growth rate (CAGR) of 3.08% from 2025 to 2032. This growth is driven by factors such as an aging population, increasing prevalence of chronic diseases, and rising demand for healthcare services.

Key drivers of the market include the expanding geriatric population, which necessitates more frequent medication use, and the increasing incidence of chronic conditions like diabetes, hypertension, and arthritis. Additionally, advancements in digital health technologies, such as telepharmacy and online prescription services, are enhancing accessibility and convenience for consumers. The integration of these technologies is expected to further propel market growth by improving patient engagement and medication adherence.

Geographically, the retail pharmacy market is concentrated in urban centers across Canada, with provinces like Ontario and Quebec housing the majority of retail pharmacy outlets. Major players in the market include McKesson Canada, Shoppers Drug Mart (a subsidiary of Loblaw Companies), and Jean Coutu Group (operated by Metro Inc.). These companies dominate the market through extensive networks of retail locations and a broad range of pharmacy services, positioning them as key contributors to the sector’s growth.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Market Insights

The Canada Retail Pharmacy Market is projected to grow from USD 39,810.35 million in 2024 to USD 50,732.50 million by 2032, at a CAGR of 3.08% from 2025 to 2032.
The Global Retail Pharmacy Market is expected to grow from USD 14,45,920.00 million in 2024 to USD 19,65,958.05 million by 2032, at a CAGR of 3.92% from 2025 to 2032.
The increasing aging population is driving demand for prescription medications and healthcare services, contributing significantly to market growth.
The rising prevalence of chronic diseases such as diabetes, hypertension, and arthritis is boosting the need for long-term medication management, expanding the retail pharmacy market.
Advancements in telepharmacy and online prescription services are improving accessibility and convenience, leading to greater market adoption and growth.
Ongoing regulatory changes and reimbursement pressures on pharmacies can limit profitability and operational flexibility, posing challenges to market players.
Ontario and Quebec hold the largest market shares, driven by urbanization, population density, and high demand for pharmaceutical services in these provinces.
Smaller provinces and rural areas are witnessing growth through digital solutions like mail-order and online pharmacies, which are enhancing accessibility and service delivery.

Report Scope

This report segments the Canada Retail Pharmacy Market as follows:

Canada Retail Pharmacy Market

Market Drivers

Advancements in Digital Health Technologies

Digital health adoption is reshaping the Canada retail pharmacy sector as pharmacies combine e-prescriptions, online refills, app-based reminders, virtual pharmacist consultations and home delivery to make medication access more convenient and continuous. This is especially relevant in rural and mobility-constrained communities, where telepharmacy and electronic prescription workflows reduce travel needs while improving speed, traceability and patient safety. A strong supporting indicator is Canada Health Infoway’s PrescribeIT program, which connects prescribers directly with pharmacy management systems to transmit prescriptions electronically, helping reduce lost, fraudulent or misused prescriptions and strengthening medication-management workflows across the care pathway. Retail pharmacies are using these digital capabilities to improve refill adherence, automate reminders, manage inventory more efficiently and expand service reach beyond store walls. As Canadian consumers increasingly expect healthcare to operate with the same ease as retail banking or e-commerce, pharmacies that integrate mobile engagement, secure digital records and remote pharmacist access are better positioned to retain customers and become everyday health-management platforms.

Government Support for Healthcare Services

Government-backed healthcare programs and pharmacy-service policies continue to reinforce the Canada retail pharmacy sector by improving access to medicines, supporting pharmacist-led care and strengthening public confidence in community-based healthcare delivery. Provincial drug plans such as Ontario Drug Benefit and BC PharmaCare help eligible populations manage medication affordability, while public health programs create demand for vaccination, smoking cessation, wellness counselling and preventive products. A useful supporting benchmark comes from the Canadian Institute for Health Information, which reported 48,450 licensed pharmacists in Canada in 2024, including 29,399 employed in direct patient care, underscoring the depth of the professional workforce available to deliver government-enabled pharmacy services. This capacity allows pharmacies to participate more actively in publicly funded vaccination campaigns, minor ailment assessment, medication reviews and chronic-care support. By aligning reimbursement, professional scope and access objectives, governments are helping pharmacies move from a dispensing-first model toward a trusted front-line care model, which improves convenience for patients and relieves pressure on physicians, clinics and hospitals.

Aging Population and Increased Healthcare Needs

Canada’s aging population is intensifying demand for retail pharmacy services because older adults typically require more prescriptions, medication reviews, adherence support, vaccination access, mobility aids and counselling for complex therapy regimens. This demographic shift is already visible: Statistics Canada reported that about 7.6 million Canadians were aged 65 and older on July 1, 2023, representing 18.9 percent of the national population, and projected that seniors could account for 21.4 percent to 23.4 percent by 2030. For retail pharmacies, this creates recurring prescription traffic and stronger demand for services such as blister packaging, home delivery, medication synchronization, chronic pain support and pharmacist-led therapy optimization. The opportunity is not only transactional; older patients often value trusted, local advice and frequent interaction with healthcare professionals. Pharmacies that build geriatric-focused service models can improve safety around polypharmacy, support aging in place and strengthen loyalty among seniors and caregivers, making community pharmacies essential partners in Canada’s broader healthcare system.

Prevalence of Chronic Diseases

The rising burden of chronic illness is a major structural driver for the Canada retail pharmacy sector, as patients with diabetes, hypertension, cardiovascular conditions, respiratory diseases and arthritis rely on frequent prescription refills, monitoring tools, OTC support and pharmacist counselling. The Public Health Agency of Canada has reported that 3 in 5 Canadians aged 20 and older live with a chronic disease and 4 in 5 are at risk of developing one, highlighting the scale of ongoing medication and disease-management needs across the country. This creates a steady role for pharmacies in adherence improvement, medication therapy reviews, refill synchronization, blood pressure monitoring, diabetes education and vaccine promotion for vulnerable groups. As healthcare systems prioritize prevention and outpatient management, retail pharmacies are becoming practical extensions of chronic-care delivery because they are accessible, familiar and frequently visited. By expanding counselling, screening and digital adherence tools, pharmacies can help re

Market Trends

Increasing Role of Pharmacists in Chronic Disease Management

Pharmacists in Canada are increasingly recognized for their role in chronic disease management. As the prevalence of chronic conditions like diabetes, hypertension, and cardiovascular diseases rises, pharmacists are playing a critical role in managing these diseases by providing medication counseling, monitoring patient adherence, and offering lifestyle advice. Many retail pharmacies are expanding their services to include comprehensive medication therapy management (MTM), where pharmacists assess a patient’s entire medication regimen and provide guidance on how to optimize treatment. This trend is driving greater collaboration between pharmacists, physicians, and other healthcare providers to ensure holistic care for patients. By enhancing their role in chronic disease management, pharmacists help improve patient outcomes and reduce the overall burden on the healthcare system, positioning retail pharmacies as essential players in the healthcare delivery model.

Emphasis on Sustainability and Eco-Friendly Practices

Sustainability has become an important trend in the Canadian retail pharmacy market, driven by both consumer demand and regulatory pressures. Pharmacies are increasingly adopting eco-friendly practices, from reducing plastic waste by offering reusable bags to implementing more energy-efficient store designs. Additionally, many retail pharmacies are shifting towards sustainable packaging for their OTC products and prescription medications. This move not only aligns with growing environmental concerns but also responds to the expectations of environmentally conscious consumers. Green initiatives, such as the recycling of pharmaceutical waste and the use of renewable energy sources in pharmacy operations, are becoming more prevalent. Furthermore, some pharmacies are expanding their product lines to include organic and eco-friendly health products, catering to consumers who prioritize sustainability in their purchasing decisions. This trend is expected to continue as both consumers and businesses embrace environmentally responsible practices.

Growth of Online Pharmacy Services

The Australian retail pharmacy market is increasingly witnessing a shift towards digital platforms. With the rise of e-commerce, more consumers are turning to online pharmacies for convenience, competitive pricing, and accessibility. For instance, during the COVID-19 pandemic, online pharmacy services in Australia saw a significant surge, with some platforms reporting a 200% increase in orders for prescription medications and health products. Retail pharmacies are responding by enhancing their digital infrastructure and offering services like e-prescriptions, online consultations, and automated prescription refills. Furthermore, the integration of mobile applications for managing medications, booking appointments, and tracking health metrics is further boosting the growth of online pharmacy services. This trend is expected to continue, with a rising number of pharmacies adopting e-commerce models to meet consumer demand for flexibility and convenience.

Expansion of Health and Wellness Offerings

The growing demand for health and wellness products is another prominent trend in Australia’s retail pharmacy market. Consumers are becoming increasingly health-conscious, seeking out products that contribute to long-term well-being and prevent the onset of chronic diseases. For example, sales of vitamins and supplements in Australian pharmacies increased by approximately 15% in the past year, reflecting the rising interest in preventive health solutions. Pharmacies are also incorporating fitness-related products like fitness trackers, sports nutrition, and personal care items into their offerings. The demand for holistic health solutions, which focus on both physical and mental well-being, is driving this expansion, and retail pharmacies are positioning themselves as one-stop shops for all health-related needs.

Market Challenges

Regulatory and Reimbursement Pressures

One of the key challenges facing the Australian retail pharmacy market is the intense price competition, particularly in an environment of rising operational costs and margin pressures. Pharmacies are faced with the challenge of maintaining profitability while offering competitive pricing to attract consumers. The growing popularity of online pharmacies has intensified price competition, as these platforms often provide lower prices and the convenience of home delivery. Traditional brick-and-mortar pharmacies are struggling to compete with these online services, especially in a market where consumers are increasingly price-sensitive and value-driven. Additionally, the Pharmaceutical Benefits Scheme (PBS) in Australia, which provides subsidized prices for certain prescription medications, creates pressure on pharmacies to adjust their pricing strategies while managing government regulations.

The pricing structure in the Australian retail pharmacy market is tightly regulated, and as a result, pharmacies have limited flexibility in setting prices for prescription drugs, which affects their profit margins. This challenge is compounded by increasing operational expenses, including rent, wages, and the cost of technology adoption. For instance, Australian pharmacies, on average, spend approximately $200,000 annually on wages, reflecting the high cost of retaining staff in the sector. These factors make it difficult for pharmacies to sustain high-profit margins. As a result, retail pharmacies are forced to find innovative ways to differentiate themselves, such as by offering additional services or expanding their product range, in order to maintain customer loyalty and competitiveness.

Competition from E-Pharmacies and Online Healthcare Platforms

The rise of e-pharmacies and online healthcare platforms represents another significant challenge for the Canada Retail Pharmacy Market. With the growing demand for convenience, many consumers are turning to online platforms to purchase medications and health products, bypassing traditional brick-and-mortar pharmacies. E-pharmacies offer the advantage of home delivery, competitive pricing, and 24/7 accessibility, making them a preferred choice for tech-savvy consumers, especially in urban areas where consumers have more access to digital health services. The COVID-19 pandemic accelerated this shift, as people became more accustomed to shopping for medications online and using telehealth services for consultations. While traditional retail pharmacies have adapted by establishing their own online services and expanding their digital presence, they continue to face stiff competition from e-pharmacies that often have lower overhead costs and more streamlined operations.

Furthermore, large online retailers like Amazon have entered the healthcare space, providing additional competition for local pharmacies. To stay competitive, traditional retail pharmacies must invest in digital technologies such as telepharmacy services, e-prescriptions, and user-friendly online platforms. Additionally, offering personalized services, such as medication therapy management and health consultations, can help retail pharmacies differentiate themselves. However, this requires significant investment and strategic planning, making it a challenge for smaller, independent pharmacies to keep pace with the digital transformation of the industry. The continued rise of online competitors poses a long-term challenge to traditional retail pharmacy models, compelling them to innovate or risk losing market share.

Market Opportunities

Expansion of Health and Wellness Services

One of the key market opportunities in the Canada Retail Pharmacy Market lies in the expansion of health and wellness services. As consumers become more health-conscious and proactive in managing their well-being, pharmacies have the opportunity to diversify their offerings beyond traditional prescription dispensing. Retail pharmacies can expand their role as healthcare hubs by offering services such as immunizations, cholesterol screenings, blood pressure monitoring, and chronic disease management programs. These services not only enhance customer engagement but also provide additional revenue streams. Moreover, pharmacies can cater to the growing demand for preventive care, which is becoming increasingly important as Canada’s aging population seeks solutions to manage long-term health. The integration of wellness programs into pharmacy offerings can also strengthen customer loyalty, as patients often prefer pharmacies that provide a one-stop solution for both healthcare and personal well-being. By investing in wellness services, retail pharmacies can tap into the expanding demand for non-prescription health products, including vitamins, dietary supplements, and natural health remedies, further broadening their product portfolio.

Adoption of Digital Health Solutions

Another significant market opportunity for retail pharmacies in Canada is the adoption of digital health solutions. The increasing reliance on technology for healthcare management presents an opportunity for pharmacies to enhance service delivery through online platforms, telepharmacy, and digital prescription management. With more Canadians seeking convenient, accessible healthcare, retail pharmacies can offer home delivery services for medications, online prescription refills, and virtual consultations with pharmacists. Additionally, integrating technologies such as AI-driven medication reminders, health tracking apps, and e-prescriptions can improve patient adherence to prescribed treatments, driving long-term customer relationships. The rise of digital health also supports pharmacy business models in underserved areas, where access to physical stores may be limited. As the demand for digital health services continues to grow, retail pharmacies that embrace these technologies are well-positioned to capture market share and deliver enhanced, convenient healthcare services.

Market Segmentation Analysis

By Type of Pharmacy

The Canada Retail Pharmacy Market is segmented by the type of pharmacy, including chain pharmacies, independent pharmacies, hospital pharmacies, mail-order pharmacies, and online pharmacies. Chain pharmacies dominate the market, benefiting from established networks, brand recognition, and economies of scale. These pharmacies have widespread locations across urban and rural areas, which enables them to reach a broad customer base. Independent pharmacies, while smaller in scale, offer personalized services and cater to local communities, often fostering long-term relationships with their customers. Hospital pharmacies primarily serve in-patients and outpatients within the hospital setting but are also expanding their retail pharmacy services to patients who require chronic disease management and specialized medications. Mail-order pharmacies cater to customers who prefer home delivery of medications, particularly those with chronic conditions requiring regular prescriptions. Online pharmacies have gained significant traction due to the growing demand for convenience, with many Canadians opting for the ease of ordering medications and health products online. These pharmacies also allow consumers to access digital consultations and telepharmacy services, further fueling their market growth.

By Type of Prescription

The retail pharmacy market in Canada is further segmented based on the type of prescription, including prescription drugs (Rx) and over-the-counter (OTC) drugs. Prescription drugs are a significant segment, as they are often used to treat chronic conditions such as diabetes, hypertension, and heart disease, which require ongoing management. The demand for prescription drugs is driven by Canada’s aging population and the increasing prevalence of chronic diseases. OTC drugs, on the other hand, are widely purchased by consumers for self-care and preventive healthcare. The rising trend of self-medication, coupled with growing awareness of health conditions, has boosted the demand for OTC drugs such as pain relievers, cold medications, and dietary supplements. Both segments are critical to the growth of retail pharmacies, with prescription drugs contributing significantly to revenue, while OTC drugs provide a substantial consumer base seeking convenience and ease of purchase.

Segments

Based on Type of Pharmacy

Chain Pharmacies
Independent Pharmacies
Hospital Pharmacies
Mail Order Pharmacies
Online Pharmacies

Based on Type of prescription

Prescription Drugs (Rx)
Over-the-Counter (OTC) Drugs

Based on Service offered

Medication Dispensing
Health Screenings
Vaccination Services
Consultation and Counseling
Chronic Disease Management

Based on Product Type

Generic Drugs
Branded Drugs

Based on Application

Oncology
Diabetes
Neurology
Other

Based on Customer

Paediatric
Adults
Geriatric

Based on Region

Ontario
Quebec
British Columbia

Regional Analysis

Ontario (38%)

Ontario holds the largest market share in the Canada Retail Pharmacy Market, contributing approximately 38% of the total market revenue. This is due to the province’s large population, urbanization, and healthcare infrastructure, which includes a significant number of retail pharmacy outlets. Ontario’s retail pharmacies benefit from a high demand for both prescription and over-the-counter (OTC) medications, bolstered by the province’s aging population and the increasing prevalence of chronic diseases. The province also has a large proportion of consumers who seek health and wellness services, further expanding the market. With strong competition among chain pharmacies like Shoppers Drug Mart and Rexall, as well as independent pharmacies, Ontario remains a key player in driving overall market growth.

Quebec (27%)

Quebec follows closely, contributing approximately 27% to the total market. The province has a unique demographic makeup with a large French-speaking population, and retail pharmacies in Quebec cater to both the linguistic and healthcare needs of this diverse group. Quebec’s healthcare system also promotes the use of generic drugs and preventive health services, which fuels demand for both prescription and OTC medications. The province’s pharmacies are increasingly adopting digital technologies, such as telepharmacy services, to enhance convenience for consumers, particularly in remote areas. Retail pharmacies in Quebec face competition from both national chains and regional players, which drives innovation and service quality.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

McKesson Canada
Shoppers Drug Mart Corporation
Costco Pharmacy
Walmart Pharmacy
Kroger Pharmacy

Competitive Analysis

The Canada Retail Pharmacy Market is highly competitive, with several key players vying for market share through diverse service offerings and strategic expansions. McKesson Canada stands as one of the leading players, offering a broad portfolio of prescription drugs and healthcare services across the country. Their extensive distribution network and focus on digital solutions for pharmacies help strengthen their market position. Shoppers Drug Mart Corporation, a subsidiary of Loblaw Companies, is another dominant player, recognized for its wide range of healthcare services and strong retail presence. Costco Pharmacy and Walmart Pharmacy are significant competitors, offering competitive pricing and leveraging their large retail networks to attract a wide customer base. Both have successfully integrated pharmacy services into their overall shopping experience, driving consumer traffic. Kroger Pharmacy, known for its strong brand in North America, is expanding its footprint in Canada, focusing on improving customer engagement through personalized pharmacy services. Together, these players are reshaping the Canadian pharmacy landscape through innovations in service delivery, product offerings, and customer experience.

Recent Developments

In December 2025, LSL Pharma Group announced the acquisition of Juno OTC Inc., adding a portfolio of Health Canada-approved OTC drugs, natural health products, and medical devices and strengthening its position as a supplier to Canadian pharmacy banners.
In January 2026, Synergy CHC expanded distribution of its FOCUSfactor functional beverage portfolio across Canada through Walmart Canada and McKesson Canada, building on its earlier supplement-SKU launch and broadening availability through pharmacy, mass, grocery, convenience, and wholesale channels.
In February 2026, Loblaw Companies, parent of Shoppers Drug Mart and Pharmaprix, announced a 2026 expansion and renovation program across its Canadian retail network, including food and pharmacy operations, with plans to open new locations and renovate existing stores.
In April 2026, Pharmacy Brands Canada launched OpenRx, a zero-fee model designed to give independent pharmacy owners access to national-scale purchasing power while allowing them to retain control of their businesses.
In May 2026, Apotex launched Apo Semaglutide Injection, a generic equivalent of Ozempic, in Canada, with initial inventory shipping to wholesalers and expected availability on pharmacy shelves across the country within weeks.

Market Concentration and Characteristics

The Canada Retail Pharmacy Market is moderately concentrated, with several dominant players controlling a significant share of the market. Key players such as McKesson Canada, Shoppers Drug Mart, and Costco Pharmacy hold a substantial portion of the market, benefiting from their extensive networks, brand recognition, and competitive pricing strategies. These companies are able to leverage economies of scale, offering a wide range of products and services, from prescription medications to health screenings and vaccinations. Independent pharmacies, although smaller in scale, contribute to the market by providing personalized services and catering to local communities. The market is also characterized by a growing trend toward digital transformation, with many pharmacies adopting e-commerce platforms, telepharmacy services, and home delivery options to enhance convenience and accessibility. The increasing presence of online pharmacies and digital health services is further intensifying competition, driving innovation, and shaping the future landscape of the market.

Report Coverage

The research report offers an in-depth analysis based on Type of Pharmacy, Type of prescription, Service offered, Product Type, Application, Customer and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The adoption of digital health solutions, including online pharmacies and telepharmacy, will continue to expand. Consumers increasingly seek the convenience of onlineordering, prescription refills, and virtual consultations.

Retail pharmacies will increasingly diversify their service offerings to include health screenings, immunizations, and chronic disease management. This shift will drive growth as pharmacies become more integrated into preventative healthcare.

Canada’s aging demographic will continue to contribute to the growing demand for prescription medications. Older adults are more likely to suffer from chronic conditions, necessitating long-term pharmaceutical care.
As cost-conscious consumers and healthcare providers turn to generic drugs, their market share will rise. Generic medications provide an affordable alternative to branded drugs, helping to manage the increasing healthcare costs.

The integration of AI-driven solutions for medication management and personalized services will enhance customer engagement. AI will improve prescription adherence and optimize inventory management in pharmacies.

With a growing focus on health and wellness, pharmacies will expand their role in preventive care. Services such as vaccinations and health screenings will become more common, contributing to a broader customer base.

Evolving regulatory policies related to drug pricing and healthcare services will impact retail pharmacies. Companies must adapt to new regulations around pricing, reimbursements, and service delivery to remain competitive.

The rise of e-pharmacies will continue to pose a challenge to traditional retail pharmacies. With increasing consumer preference for convenience, established pharmacies must innovate to maintain market share.

Ongoing reforms in healthcare insurance and drug coverage policies will directly affect consumer spending on pharmacy services. Retail pharmacies will need to adjust their offerings to align with changing reimbursement structures.

As environmental concerns rise, pharmacies will focus on adopting sustainable practices. Green initiatives such as reducing plastic waste and using eco-friendly packaging will become essential to meet consumer expectations and regulatory demands.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Canada Retail Pharmacy Market Snapshot 21

2.1.1. Canada Retail Pharmacy Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : CANADA RETAIL PHARMACY MARKET – INDUSTRY ANALYSIS 23

3.1. Introduction 23

3.2. Market Drivers 24

3.2.1. Increasing Health Awareness 24

3.2.2. Growing E-Commerce and Online Pharmacies 25

3.3. Market Restraints 26

3.3.1. Regulatory and Pricing Controls 26

3.4. Market Opportunities 27

3.4.1. Market Opportunity Analysis 27

3.5. Porter’s Five Forces Analysis 28

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 29

4.1. Company Market Share Analysis – 2024 29

4.1.1. Canada Retail Pharmacy Market: Company Market Share, by Volume, 2024 29

4.1.2. Canada Retail Pharmacy Market: Company Market Share, by Revenue, 2024 30

4.1.3. Canada Retail Pharmacy Market: Top 6 Company Market Share, by Revenue, 2024 30

4.1.4. Canada Retail Pharmacy Market: Top 3 Company Market Share, by Revenue, 2024 31

4.2. Canada Retail Pharmacy Market Company Revenue Market Share, 2024 32

4.3. Company Assessment Metrics, 2024 33

4.3.1. Stars 33

4.3.2. Emerging Leaders 33

4.3.3. Pervasive Players 33

4.3.4. Participants 33

4.4. Start-ups /SMEs Assessment Metrics, 2024 33

4.4.1. Progressive Companies 33

4.4.2. Responsive Companies 33

4.4.3. Dynamic Companies 33

4.4.4. Starting Blocks 33

4.5. Strategic Developments 34

4.5.1. Acquisitions & Mergers 34

New Product Launch 34

Regional Expansion 34

4.6. Key Players Product Matrix 35

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 36

5.1. PESTEL 36

5.1.1. Political Factors 36

5.1.2. Economic Factors 36

5.1.3. Social Factors 36

5.1.4. Technological Factors 36

5.1.5. Environmental Factors 36

5.1.6. Legal Factors 36

5.2. Adjacent Market Analysis 36

CHAPTER NO. 6 : CANADA RETAIL PHARMACY MARKET – BY TYPE OF PHARMACY SEGMENT ANALYSIS 37

6.1. Canada Retail Pharmacy Market Overview, by Type of Pharmacy Segment 37

6.1.1. Canada Retail Pharmacy Market Revenue Share, By Type of Pharmacy, 2023 & 2032 38

6.1.2. Canada Retail Pharmacy Market Attractiveness Analysis, By Type of Pharmacy 39

6.1.3. Incremental Revenue Growth Opportunity, by Type of Pharmacy, 2024 – 2032 39

6.1.4. Canada Retail Pharmacy Market Revenue, By Type of Pharmacy, 2018, 2023, 2027 & 2032 40

6.2. Chain Pharmacies 41

6.3. Independent Pharmacies 42

6.4. Hospital Pharmacies 43

6.5. Mail Order Pharmacies 44

6.6. Online Pharmacies 45

CHAPTER NO. 7 : CANADA RETAIL PHARMACY MARKET – BY TYPE OF PRESCRIPTION SEGMENT ANALYSIS 46

7.1. Canada Retail Pharmacy Market Overview, by Type of Prescription Segment 46

7.1.1. Canada Retail Pharmacy Market Revenue Share, By Type of Prescription, 2023 & 2032 47

7.1.2. Canada Retail Pharmacy Market Attractiveness Analysis, By Type of Prescription 48

7.1.3. Incremental Revenue Growth Opportunity, by Type of Prescription, 2024 – 2032 48

7.1.4. Canada Retail Pharmacy Market Revenue, By Type of Prescription, 2018, 2023, 2027 & 2032 49

7.2. Prescription Drugs (Rx) 50

7.3. Over-the-Counter (OTC) Drugs 51

CHAPTER NO. 8 : CANADA RETAIL PHARMACY MARKET – BY SERVICE OFFERED SEGMENT ANALYSIS 52

8.1. Canada Retail Pharmacy Market Overview, by Service Offered Segment 52

8.1.1. Canada Retail Pharmacy Market Revenue Share, By Service Offered, 2023 & 2032 53

8.1.2. Canada Retail Pharmacy Market Attractiveness Analysis, By Service Offered 54

8.1.3. Incremental Revenue Growth Opportunity, by Service Offered, 2024 – 2032 54

8.1.4. Canada Retail Pharmacy Market Revenue, By Service Offered, 2018, 2023, 2027 & 2032 55

8.2. Medication Dispensing 56

8.3. Health Screenings 57

8.4. Vaccination Services 58

8.5. Consultation and Counseling 59

8.6. Chronic Disease Management 60

CHAPTER NO. 9 : CANADA RETAIL PHARMACY MARKET – BY PRODUCT TYPE SEGMENT ANALYSIS 61

9.1. Canada Retail Pharmacy Market Overview, by Product Type Segment 61

9.1.1. Canada Retail Pharmacy Market Revenue Share, By Product Type, 2023 & 2032 62

9.1.2. Canada Retail Pharmacy Market Attractiveness Analysis, By Product Type 63

9.1.3. Incremental Revenue Growth Opportunity, by Product Type, 2024 – 2032 63

9.1.4. Canada Retail Pharmacy Market Revenue, By Product Type, 2018, 2023, 2027 & 2032 64

9.2. Generic Drugs 65

9.3. Branded Drugs 66

CHAPTER NO. 10 : CANADA RETAIL PHARMACY MARKET – BY APPLICATION SEGMENT ANALYSIS 67

10.1. Canada Retail Pharmacy Market Overview, by Application Segment 67

10.1.1. Canada Retail Pharmacy Market Revenue Share, By Application , 2023 & 2032 68

10.1.2. Canada Retail Pharmacy Market Attractiveness Analysis, By Application 69

10.1.3. Incremental Revenue Growth Opportunity, by Application , 2024 – 2032 69

10.1.4. Canada Retail Pharmacy Market Revenue, By Application , 2018, 2023, 2027 & 2032 70

10.2. Oncology 71

10.3. Diabetes 72

10.4. Neurology 73

10.5. Others 74

CHAPTER NO. 11 : CANADA RETAIL PHARMACY MARKET – BY CUSTOMER SEGMENT ANALYSIS 75

11.1. Canada Retail Pharmacy Market Overview, by Customer Segment 75

11.1.1. Canada Retail Pharmacy Market Revenue Share, By Customer Segment, 2023 & 2032 76

11.1.2. Canada Retail Pharmacy Market Attractiveness Analysis, By Customer Segment 77

11.1.3. Incremental Revenue Growth Opportunity, by Customer Segment, 2024 – 2032 77

11.1.4. Canada Retail Pharmacy Market Revenue, By Customer Segment, 2018, 2023, 2027 & 2032 78

11.2. Paediatric 79

11.3. Adults 80

11.4. Geriatric 80

CHAPTER NO. 12 : CANADA RETAIL PHARMACY MARKET – ANALYSIS 81

12.1. Type of Pharmacy 81

12.1.1. Canada Retail Pharmacy Market Revenue, By Type of Pharmacy, 2018 – 2023 (USD Million) 81

12.1.2. Canada Retail Pharmacy Market Revenue, By Type of Pharmacy, 2024 – 2032 (USD Million) 81

12.2. Type of Prescription 82

12.2.1. Canada Retail Pharmacy Market Revenue, By Type of Prescription, 2018 – 2023 (USD Million) 82

12.2.2. Canada Retail Pharmacy Market Revenue, By Type of Prescription, 2024 – 2032 (USD Million) 82

12.3. Service Offered 83

12.3.1. Canada Retail Pharmacy Market Revenue, By Service Offered, 2018 – 2023 (USD Million) 83

12.3.2. Canada Retail Pharmacy Market Revenue, By Service Offered, 2024 – 2032 (USD Million) 83

12.4. Product Type 84

12.4.1. Canada Retail Pharmacy Market Revenue, By Product Type, 2018 – 2023 (USD Million) 84

12.4.2. Canada Retail Pharmacy Market Revenue, By Product Type, 2024 – 2032 (USD Million) 84

12.5. Application 85

12.5.1. Canada Retail Pharmacy Market Revenue, By Application, 2018 – 2023 (USD Million) 85

12.5.2. Canada Retail Pharmacy Market Revenue, By Application, 2024 – 2032 (USD Million) 85

12.6. Customer Segment 86

12.6.1. Canada Retail Pharmacy Market Revenue, By Customer Segment, 2018 – 2023 (USD Million) 86

12.6.2. Canada Retail Pharmacy Market Revenue, By Customer Segment, 2024 – 2032 (USD Million) 86

CHAPTER NO. 13 : COMPANY PROFILES 87

13.1. McKesson Canada 87

13.1.1. Company Overview 87

13.1.2. Product Portfolio 87

13.1.3. Swot Analysis 87

13.1.4. Business Strategy 88

13.1.5. Financial Overview 88

13.2. Shoppers Drug Mart Corporation 89

13.3. Costco Pharmacy 89

13.4. Walmart Pharmacy 89

13.5. Kroger Pharmacy 89

13.6. Company 6 89

13.7. Company 7 89

13.8. Company 8 89

13.9. Company 9 89

13.10. Company 10 89

List of Figures

FIG NO. 1. Canada Retail Pharmacy Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Canada Retail Pharmacy Market 28

FIG NO. 3. Company Share Analysis, 2024 29

FIG NO. 4. Company Share Analysis, 2024 30

FIG NO. 5. Company Share Analysis, 2024 30

FIG NO. 6. Company Share Analysis, 2024 31

FIG NO. 7. Canada Retail Pharmacy Market – Company Revenue Market Share, 2024 32

FIG NO. 8. Canada Retail Pharmacy Market Revenue Share, By Type of Pharmacy, 2023 & 2032 38

FIG NO. 9. Market Attractiveness Analysis, By Type of Pharmacy 39

FIG NO. 10. Incremental Revenue Growth Opportunity by Type of Pharmacy, 2024 – 2032 39

FIG NO. 11. Canada Retail Pharmacy Market Revenue, By Type of Pharmacy, 2018, 2023, 2027 & 2032 40

FIG NO. 12. Canada Retail Pharmacy Market for Chain Pharmacies, Revenue (USD Million) 2018 – 2032 41

FIG NO. 13. Canada Retail Pharmacy Market for Independent Pharmacies, Revenue (USD Million) 2018 – 2032 42

FIG NO. 14. Canada Retail Pharmacy Market for Hospital Pharmacies, Revenue (USD Million) 2018 – 2032 43

FIG NO. 15. Canada Retail Pharmacy Market for Mail Order Pharmacies, Revenue (USD Million) 2018 – 2032 44

FIG NO. 16. Canada Retail Pharmacy Market for Online Pharmacies, Revenue (USD Million) 2018 – 2032 45

FIG NO. 17. Canada Retail Pharmacy Market Revenue Share, By Type of Prescription, 2023 & 2032 47

FIG NO. 18. Market Attractiveness Analysis, By Type of Prescription 48

FIG NO. 19. Incremental Revenue Growth Opportunity by Type of Prescription, 2024 – 2032 48

FIG NO. 20. Canada Retail Pharmacy Market Revenue, By Type of Prescription, 2018, 2023, 2027 & 2032 49

FIG NO. 21. Canada Retail Pharmacy Market for Prescription Drugs (Rx), Revenue (USD Million) 2018 – 2032 50

FIG NO. 22. Canada Retail Pharmacy Market for Over-the-Counter (OTC) Drugs, Revenue (USD Million) 2018 – 2032 51

FIG NO. 23. Canada Retail Pharmacy Market Revenue Share, By Service Offered, 2023 & 2032 53

FIG NO. 24. Market Attractiveness Analysis, By Service Offered 54

FIG NO. 25. Incremental Revenue Growth Opportunity by Service Offered, 2024 – 2032 54

FIG NO. 26. Canada Retail Pharmacy Market Revenue, By Service Offered, 2018, 2023, 2027 & 2032 55

FIG NO. 27. Canada Retail Pharmacy Market for Medication Dispensing, Revenue (USD Million) 2018 – 2032 56

FIG NO. 28. Canada Retail Pharmacy Market for Health Screenings, Revenue (USD Million) 2018 – 2032 57

FIG NO. 29. Canada Retail Pharmacy Market for Vaccination Services, Revenue (USD Million) 2018 – 2032 58

FIG NO. 30. Canada Retail Pharmacy Market for Consultation and Counseling, Revenue (USD Million) 2018 – 2032 59

FIG NO. 31. Canada Retail Pharmacy Market for Chronic Disease Management, Revenue (USD Million) 2018 – 2032 60

FIG NO. 32. Canada Retail Pharmacy Market Revenue Share, By Product Type, 2023 & 2032 62

FIG NO. 33. Market Attractiveness Analysis, By Product Type 63

FIG NO. 34. Incremental Revenue Growth Opportunity by Product Type, 2024 – 2032 63

FIG NO. 35. Canada Retail Pharmacy Market Revenue, By Product Type, 2018, 2023, 2027 & 2032 64

FIG NO. 36. Canada Retail Pharmacy Market for Generic Drugs, Revenue (USD Million) 2018 – 2032 65

FIG NO. 37. Canada Retail Pharmacy Market for Branded Drugs, Revenue (USD Million) 2018 – 2032 66

FIG NO. 38. Canada Retail Pharmacy Market Revenue Share, By Application , 2023 & 2032 68

FIG NO. 39. Market Attractiveness Analysis, By Application 69

FIG NO. 40. Incremental Revenue Growth Opportunity by Application , 2024 – 2032 69

FIG NO. 41. Canada Retail Pharmacy Market Revenue, By Application , 2018, 2023, 2027 & 2032 70

FIG NO. 42. Canada Retail Pharmacy Market for Oncology, Revenue (USD Million) 2018 – 2032 71

FIG NO. 43. Canada Retail Pharmacy Market for Diabetes, Revenue (USD Million) 2018 – 2032 72

FIG NO. 44. Canada Retail Pharmacy Market for Neurology, Revenue (USD Million) 2018 – 2032 73

FIG NO. 45. Canada Retail Pharmacy Market for Others, Revenue (USD Million) 2018 – 2032 74

FIG NO. 46. Canada Retail Pharmacy Market Revenue Share, By Customer Segment, 2023 & 2032 76

FIG NO. 47. Market Attractiveness Analysis, By Customer Segment 77

FIG NO. 48. Incremental Revenue Growth Opportunity by Customer Segment, 2024 – 2032 77

FIG NO. 49. Canada Retail Pharmacy Market Revenue, By Customer Segment, 2018, 2023, 2027 & 2032 78

FIG NO. 50. Canada Retail Pharmacy Market for Pediatric, Revenue (USD Million) 2018 – 2032 79

FIG NO. 51. Canada Retail Pharmacy Market for Adults, Revenue (USD Million) 2018 – 2032 80

FIG NO. 52. Canada Retail Pharmacy Market for Geriatric, Revenue (USD Million) 2018 – 2032 80

List of Tables

TABLE NO. 1. : Canada Retail Pharmacy Market: Snapshot 21

TABLE NO. 2. : Drivers for the Canada Retail Pharmacy Market: Impact Analysis 24

TABLE NO. 3. : Restraints for the Canada Retail Pharmacy Market: Impact Analysis 26

TABLE NO. 4. : Canada Retail Pharmacy Market Revenue, By Type of Pharmacy, 2018 – 2023 (USD Million) 81

TABLE NO. 5. : Canada Retail Pharmacy Market Revenue, By Type of Pharmacy, 2024 – 2032 (USD Million) 81

TABLE NO. 6. : Canada Retail Pharmacy Market Revenue, By Type of Prescription, 2018 – 2023 (USD Million) 82

TABLE NO. 7. : Canada Retail Pharmacy Market Revenue, By Type of Prescription, 2024 – 2032 (USD Million) 82

TABLE NO. 8. : Canada Retail Pharmacy Market Revenue, By Service Offered, 2018 – 2023 (USD Million) 83

TABLE NO. 9. : Canada Retail Pharmacy Market Revenue, By Service Offered, 2024 – 2032 (USD Million) 83

TABLE NO. 10. : Canada Retail Pharmacy Market Revenue, By Product Type, 2018 – 2023 (USD Million) 84

TABLE NO. 11. : Canada Retail Pharmacy Market Revenue, By Product Type, 2024 – 2032 (USD Million) 84

TABLE NO. 12. : Canada Retail Pharmacy Market Revenue, By Application, 2018 – 2023 (USD Million) 85

TABLE NO. 13. : Canada Retail Pharmacy Market Revenue, By Application, 2024 – 2032 (USD Million) 85

TABLE NO. 14. : Canada Retail Pharmacy Market Revenue, By Customer Segment, 2018 – 2023 (USD Million) 86

TABLE NO. 15. : Canada Retail Pharmacy Market Revenue, By Customer Segment, 2024 – 2032 (USD Million) 86

Request A Free Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

Frequently Asked Questions

What is the current market size of the Canada Retail Pharmacy Market?

The Canada Retail Pharmacy Market is projected to reach USD 39,810.35 million in 2024. It is expected to grow to USD 50,732.50 million by 2032, with a compound annual growth rate (CAGR) of 3.08% from 2025 to 2032.

What factors are driving growth in the Canada Retail Pharmacy Market?

Key growth drivers include an aging population, increasing prevalence of chronic diseases, and rising demand for healthcare services. Advancements in digital health technologies like telepharmacy and online prescription services are also contributing to the market’s expansion.

Who are the major players in the Canada Retail Pharmacy Market?

Major players in the market include McKesson Canada, Shoppers Drug Mart (Loblaw Companies), and Jean Coutu Group (Metro Inc.). These companies dominate through extensive retail networks and a wide range of pharmacy services.

How is the shift towards digital health impacting the retail pharmacy market?

The adoption of telepharmacy and online prescription services is improving accessibility and convenience for consumers. These technological advancements are expected to enhance patient engagement and medication adherence, boosting market growth.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

Autologous Conditioned Plasma (ACP) Market

Autologous Conditioned Plasma (ACP) Market size was valued USD 584 million in 2024 and is anticipated to reach USD 1366.31 million by 2032, at a CAGR of 11.2% during the forecast period.

Autogenous Vaccine Market

Autogenous Vaccine Market size was valued USD 465 million in 2024 and is anticipated to reach USD 810.46 million by 2032, at a CAGR of 7.2% during the forecast period.

Combination Therapies In Aesthetics Market

The global combination therapies in aesthetics market was valued at USD 3,690 million in 2024 and is projected to reach USD 6,880.69 million by 2032, expanding at a compound annual growth rate (CAGR) of 8.1% during the forecast period.

Antioxidants Market

The global antioxidants market was valued at USD 4,095.8 million in 2024 and is anticipated to reach USD 6,657.29 million by 2032, expanding at a CAGR of 6.26% during the forecast period.

U.S. Pharma R&D Outsourcing Market

US Pharma R&D Outsourcing Market size was valued at USD 30,916.90 Million in 2024 and is anticipated to reach USD 67,782.11 Million by 2032, at a CAGR of 10.31% during the forecast period.

Reversible Airway Diseases Treatment Market

The Reversible Airway Diseases Treatment Market size was valued at USD 85,518 million in 2024 and is anticipated to reach USD 143671.9 million by 2032, at a CAGR of 6.7 % during the forecast period.

Precision Medicine Market

The Precision Medicine Market size was valued at USD 91,298 million in 2024 and is anticipated to reach USD 204409.6 million by 2032, at a CAGR of 10.6 % during the forecast period.

Postpartum Depression Market

The Postpartum Depression Market size was valued at USD 68 million in 2024 and is anticipated to reach USD 815.92 million by 2032, at a CAGR of 36.5% during the forecast period.

Metastatic Melanoma Cancer Diagnostics Market

The Metastatic Melanoma Cancer Diagnostics Market size was valued at USD 3,622 million in 2024 and is anticipated to reach USD 6364.41 million by 2032, at a CAGR of 7.3 % during the forecast period.

Flavored Empty Capsule Market

The flavored empty capsule market was valued at USD 5,659 million in 2024. The market is projected to reach USD 10,319.51 million by 2032. Growth is expected at a CAGR of 7.8% during the forecast period.

Diabetic Foot Ulcer Treatment Market

The global Diabetic Foot Ulcer Treatment Market size was estimated at USD 5,642.83 million in 2025 and is expected to reach USD 8,796.45 million by 2032, growing at a CAGR of 7.68% from 2025 to 2032.

Dextromethorphan Market

The global Dextromethorphan Market size was estimated at USD 1,284.56 million in 2025 and is expected to reach USD 1,689.23 million by 2032, growing at a CAGR of 4.67% from 2025 to 2032.

Licence Option

Single User

$2999

Multi User

$3999

Enterprise

$5999

Report delivery within 24 to 48 hours

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample